NVIDIA Corporation vs. Scribe Therapeutics Inc. Common Stock
NVIDIA Corporation (NVDA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| NVDA | SCTX | |
|---|---|---|
| Market Cap | $5.08 trillion | $598.00 million |
| Revenue (TTM) | $253.49 billion | — |
| Net Income (TTM) | $159.61 billion | — |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| NVDA | SCTX | |
|---|---|---|
| P/E Ratio | 34.87 | — |
| Price / Book | 25.98 | — |
| Price / Sales | 20.03 | — |
NVDA and SCTX split the valuation factors evenly.
Profitability
| NVDA | SCTX | |
|---|---|---|
| Net Margin | 62.97% | — |
| Return on Equity | 81.65% | — |
NVDA and SCTX split the profitability factors evenly.
Dividend
| NVDA | SCTX | |
|---|---|---|
| Dividend Yield | 0.44% | — |
| Payout Ratio | 15.31 | — |
NVDA and SCTX split the dividend factors evenly.
Risk & Sentiment
| NVDA | SCTX | |
|---|---|---|
| Short Interest | 0.07% | 1.39% |
NVDA leads on 1 of 1 risk & sentiment factors.
Dig deeper: NVDA overview, NVDA financials, SCTX overview, SCTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.